Increasing prevalence of chronic diseases and the need for personalized medicines is expected to drive the global clinical trials market through 2026. According to TechSci Research report, “Global Clinical Trials Market By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Autoimmune/Inflammation, Oncology, CNS, Diabetes, Cardiovascular, Others), By Type